BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31321084)

  • 1. NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
    Pan C; Izreig S; Yarbrough WG; Issaeva N
    Cancers Head Neck; 2019; 4():3. PubMed ID: 31321084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
    Gameiro SF; Ghasemi F; Zeng PYF; Mundi N; Howlett CJ; Plantinga P; Barrett JW; Nichols AC; Mymryk JS
    Infect Agent Cancer; 2021 Feb; 16(1):13. PubMed ID: 33588906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of
    Bui N; Huang JK; Bojorquez-Gomez A; Licon K; Sanchez KS; Tang SN; Beckett AN; Wang T; Zhang W; Shen JP; Kreisberg JF; Ideker T
    Mol Cancer Ther; 2018 Jul; 17(7):1585-1594. PubMed ID: 29636367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
    Ghasemi F; Prokopec SD; MacNeil D; Mundi N; Gameiro SF; Howlett C; Stecho W; Plantinga P; Pinto N; Ruicci KM; Khan MI; Yoo J; Fung K; Sahovaler A; Palma DA; Winquist E; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
    JCI Insight; 2019 Jan; 4(1):. PubMed ID: 30626742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
    Topchu I; Bychkov I; Gursel D; Makhov P; Boumber Y
    bioRxiv; 2023 Sep; ():. PubMed ID: 37786686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
    Topchu I; Bychkov I; Gursel D; Makhov P; Boumber Y
    Cell Death Discov; 2024 Feb; 10(1):75. PubMed ID: 38346948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
    Tian G; Fu Y; Zhang D; Li J; Zhang Z; Yang X
    Cancer Cell Int; 2021 Mar; 21(1):167. PubMed ID: 33712015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
    Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
    Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Topchu I; Bychkov I; Roshchina E; Makhov P; Boumber Y
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
    Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N
    Clin Cancer Res; 2012 Mar; 18(5):1257-67. PubMed ID: 22247495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic insights into head and neck cancer.
    Beck TN; Golemis EA
    Cancers Head Neck; 2016; 1():. PubMed ID: 29034103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
    Prusinkiewicz MA; Gameiro SF; Ghasemi F; Dodge MJ; Zeng PYF; Maekebay H; Barrett JW; Nichols AC; Mymryk JS
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.